September 11, 2013 Cancer/Oncology Genentech asking FDA for accelerated approval for drug to treat early-stage HER-2 breast cancer
October 3, 2012 Cancer/Oncology Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study
December 13, 2010 Cancer/Oncology Combination therapy for invasive non-metastatic HER-2 breast cancer shows promise